Secret behind diabetes drug's benefits revealed

Secret behind diabetes drug's benefits revealed
Hertzel Gerstein, left, professor of medicine; Emily Day, PhD medical sciences student, and Gregory Steinberg, professor of medicine at McMaster University. Credit: McMaster University

Researchers at McMaster University have unlocked one of the secrets behind the many benefits of metformin.

One of the most widely used medications in the world; is commonly prescribed for Type 2 diabetes. However, in addition to its effects on lowering , in preclinical models, metformin shows benefits on aging and a number of diverse diseases such as cognitive disorders, cancer and .

One question researchers have been asking is how this is being achieved.

A multi-year study led by a collaboration of McMaster's basic science and clinical researchers has found that metformin induces the expression and secretion of a protein called growth differentiating factor 15, or GDF15.

The results were published today in Nature Metabolism.

"Studies over the past two decades have shown that metformin does more than lower glucose, but we haven't understood why," said Gregory Steinberg, senior author and professor of medicine at McMaster. He is also co-director of the Centre for Metabolism, Obesity and Diabetes Research at McMaster.

"We went into this study with the idea that metformin might communicate with other tissues in the body by causing the secretion of a protein from the liver. We were totally surprised when we found out that metformin caused the secretion of GDF15, a protein which is known to suppress appetite."

The study team took that knowledge and applied it to mice to better understand the science behind the outcome. Scientists deleted the gene that makes GDF15 in mice, then treated them with metformin. The results showed that mice without GDF15 did not eat less or lose weight, despite being administered metformin, establishing GDF15 as the connection between metformin and weight loss.

The researchers say the findings open a number of avenues of research. There are currently over 1,500 registered to test the effects of metformin in aging and different diseases.

"The possibility that GDF15 has a role in multiple beneficial effects of metformin treatment on aging or diseases like cancer needs to be studied," Steinberg said.

More information: Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss, Nature Metabolism (2019). DOI: 10.1038/s42255-019-0146-4 ,

Journal information: Nature Metabolism
Citation: Secret behind diabetes drug's benefits revealed (2019, December 9) retrieved 2 March 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Serum biomarker that reflects use, dose of metformin identified


Feedback to editors